• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Cleveland Clinic Taps Theranos for Innovative Lab Testing

by Fred Pennic 03/10/2015 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Cleveland_Clinic_logo

Cleveland Clinic and Theranos Inc. have formed a long-term strategic alliance designed to improve patient care through innovation utilizing Theranos’ CLIA-certified laboratory services. Under the new alliance, Cleveland Clinic’s best-in-class pathology team in the Robert J. Tomsich Pathology and Laboratory Medicine Institute will collaborate with Theranos to provide advanced clinical diagnostic services and, over time, implement Theranos’ groundbreaking, CLIA-certified laboratory services within Cleveland Clinic’s patient populations.

“This alliance with a world-renowned health system like Cleveland Clinic furthers our mission, and is another step in our work to bring access to high-quality, affordable lab testing to everyone and help improve the quality and cost of care”

Theranos and Cleveland Clinic

Theranos offers a full spectrum of laboratory tests, from the most common panels to highly specialized tests, on blood samples as small as a few drops. This eliminates the need for larger needles and numerous vials of blood required for many diagnostic lab tests. Theranos’ minimally invasive sample collection will serve patients such as those receiving oncologic, pediatric and other inpatient treatment requiring frequent blood draws. Theranos tests are also priced at 50 percent of Medicare reimbursement rates or less to reduce the overall cost of care.

“Healthcare innovation is essential to making care more accessible, affordable and timely for patients. This relationship could open up new opportunities for both patients and physicians to be part of high-quality, low-cost healthcare,” said Toby Cosgrove, M.D., President and CEO of Cleveland Clinic. “We’re excited to begin exploring new initiatives that can offer improved care for our patient’s healthcare dollar.”

As part of the strategic alliance, Theranos and Cleveland Clinic will include opportunities to pursue research studies, clinical trials, the development of new tests, and the provision of reference laboratory services through Cleveland Clinic Laboratories. The collaboration may also extend to other Cleveland Clinic hospitals and family health centers.

Theranos currently provides its laboratory services through its network of Theranos Wellness Centers, located inside select Walgreens stores across Arizona and in Northern California.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Interview

Reach7 Diabetes Studios Founder Chun Yong on Reimagining Chronic Care with a Concierge Medical Model

Most-Read

HHS Finalizes HTI-4 Rule: Prior Authorization & E-Prescribing Interoperability

HHS Finalizes HTI-4 Rule: Prior Authorization & E-Prescribing Interoperability

Meaningful Use Penalties_Meaningful Use_Partial Code Free_Senators Urge CMS to Establish Clear Metrics for ICD-10 Testing

CMS Finalizes TEAM Model: A New Era of Value-Based Surgical Care

White House Event Unveils CMS Health Tech Ecosystem Initiative

White House Event Unveils CMS Health Tech Ecosystem Initiative

Digital Health Faces Q2'25 Pullback: Funding Falls to 5-Year Low, But AI Dominates and $1B+ IPOs Emerge

Healthcare Investment Shifts in 1H 2025: AI Remains a Bright Spot Amidst Fundraising Decline

Digital Health Faces Q2'25 Pullback: Funding Falls to 5-Year Low

Digital Health Faces Q2’25 Pullback: Funding Falls to 5-Year Low

Beyond the Hype: Building AI Systems in Healthcare Where Hallucinations Are Not an Option

Beyond the Hype: Building AI Systems in Healthcare Where Hallucinations Are Not an Option

Health IT Sector Navigates Policy Turbulence with Resilient M&A

Health IT’s New Chapter: IPOs Return, Resilient M&A, Valuations Rise in 1H 2025

PwC Report: US Medical Cost Trend to Remain Elevated at 8.5% in 2026

PwC Report: US Medical Cost Trend to Remain Elevated at 8.5% in 2026

Philips Launches ECG AI Marketplace, Partnering with Anumana to Enhance Cardiac Care with AI-Powered Diagnostics

Philips Launches ECG AI Marketplace, Partnering with Anumana to Enhance Cardiac Care with AI-Powered Diagnostics

WeightWatchers Emerges from Bankruptcy, Launches New Menopause Program

WeightWatchers Emerges from Bankruptcy, Launches New Menopause Program

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |